| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8804327 | The Spine Journal | 2018 | 7 Pages |
Abstract
Cerebrolysin over 4 weeks is safe and effective for the improvement of CSM as compared with placebo, with no reported cases of neurologic deterioration over 6 months of follow-up.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Ahmad Fouad Abdelbaki MD, MRCS, Tarek Abdalla Ahmed MD, Wael MD,